Indiana mental health bill advances out of House committee
A sweeping bill that would create a new mental health care system in Indiana drew tears and personal testimony Tuesday–from both the public and elected officials.
A sweeping bill that would create a new mental health care system in Indiana drew tears and personal testimony Tuesday–from both the public and elected officials.
Indiana Gov. Eric Holcomb faces a Wednesday deadline to make a decision on a bill that would prohibit transgender youth from accessing hormone therapies, puberty blockers and surgeries in the state.
David McIntosh will succeed Dennis May, who has served in the role since 2016 and will transition to executive chairman of the board.
A federal judge who previously ruled to dismantle the Affordable Care Act struck down a narrower but key part of the nation’s health law Thursday that requires most insurers to cover preventive services that include screenings for cancer, diabetes and mental health.
State senators and health care stakeholders alike seemed unable to find much agreement Wednesday on how to address Indiana’s health care costs, or even how to measure and compare those costs to neighboring states.
Eskenazi Health said it will set up three “health equity zones” in low-income areas of Marion County with neighborhood leaders and residents to increase access to health care, mental health care and nutritious foods.
GeniPhys has developed a material known as Collymer, a highly-purified form of collagen that can be used to replace tissue that is lost in wounds and also forms “stable, fibrillar collagen scaffolds” that can help rebuild lost tissue.
The bill would prohibit transgender youth under 18 from accessing hormone therapies, puberty blockers and surgeries in the state.
Ascension, the largest health system in central Indiana by number of beds, did not name a successor. It said in the announcement it “will be working through a thoughtful transition plan.”
A wave of adoptions during the COVID-19 pandemic has created greater demand for basics like food and toys, as well as sophisticated medical care that can prolong a pet’s life.
Founded in 2021, Blue Agilis helps health care providers customize their care based on research and provides a structure to make sure that care gets delivered.
The 5th U.S. Circuit Court of Appeals in New Orleans rejected arguments that Biden, as the nation’s chief executive, has the same authority as the CEO of a private corporation to require that employees be vaccinated.
Moody’s action pushed Elanco’s credit rating further into “junk bond” territory, an area considered riskier than investment-grade debt.
The government announced plans Wednesday to overhaul the troubled U.S. organ transplant system, including breaking up the monopoly power of the not-for-profit organization that has run it for the past 37 years.
The donation comes from the former CEO of Santa Barbara Specialty Pharmacy, which services California and five nearby states.
Illuccix was first approved by the FDA in December 2021. The imaging agent is designed to target and “light up” cancerous cells, making it easier for oncologists to determine through a PET scan if the cells have spread to areas outside the prostate.
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.
The Hoosier State continues to lag its peers when it comes to child wellbeing, ranking 28th overall—just one place ahead of its ranking last year. But it has made strides in reducing the number of foster children in the state.
Fred Cate, IU’s vice president for research, informed federal officials that the research group had “a pattern of non-compliance” and had been warned several times against using expired materials.
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly and Co.